These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11591503)

  • 21. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
    Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
    Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The contribution of thrombin-induced platelet activation to thrombus growth is diminished under pathological blood shear conditions.
    Lee H; Sturgeon SA; Jackson SP; Hamilton JR
    Thromb Haemost; 2012 Feb; 107(2):328-37. PubMed ID: 22187047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis.
    Leger AJ; Jacques SL; Badar J; Kaneider NC; Derian CK; Andrade-Gordon P; Covic L; Kuliopulos A
    Circulation; 2006 Mar; 113(9):1244-54. PubMed ID: 16505172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of protease-activated receptor 4-dependent platelet activation by YD-3.
    Wu CC; Hwang TL; Liao CH; Kuo SC; Lee FY; Lee CY; Teng CM
    Thromb Haemost; 2002 Jun; 87(6):1026-33. PubMed ID: 12083482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of new peptide-based ureas and thioureas as potential antagonists of the thrombin receptor PAR1.
    Ventosa-Andrés P; Valdivielso AM; Pappos I; García-López MT; Tsopanoglou NE; Herranz R
    Eur J Med Chem; 2012 Dec; 58():98-111. PubMed ID: 23123726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation.
    Burke FM; Warnock M; Schmaier AH; Mosberg HI
    Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SCH 530348: a novel oral thrombin receptor antagonist.
    Bonaca MP; Morrow DA
    Future Cardiol; 2009 Sep; 5(5):435-42. PubMed ID: 19715408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombin-receptor agonist peptides, in contrast to thrombin itself, are not full agonists for activation and signal transduction in human platelets in the absence of platelet-derived secondary mediators.
    Lau LF; Pumiglia K; Côté YP; Feinstein MB
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):391-400. PubMed ID: 7526841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet thrombin receptor antagonism with vorapaxar: pharmacology and clinical trial development.
    Franchi F; Rollini F; Park Y; Angiolillo DJ
    Future Cardiol; 2015 Sep; 11(5):547-64. PubMed ID: 26406386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and synthesis of a novel series of quinoline-based thrombin receptor (PAR-1) antagonists.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Bryant M; Lau J
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1544-8. PubMed ID: 16380251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.
    Schmid W; Vogelsang H; Papay P; Primas C; Eser A; Gratzer C; Handler M; Novacek G; Panzer S
    J Crohns Colitis; 2014 Jun; 8(6):495-503. PubMed ID: 24291018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of potent thrombin receptor antagonist peptides.
    Bernatowicz MS; Klimas CE; Hartl KS; Peluso M; Allegretto NJ; Seiler SM
    J Med Chem; 1996 Dec; 39(25):4879-87. PubMed ID: 8960546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential anti-thrombotic benefit and bleeding risk profiles of antagonists of protease-activated receptor 1 and 4 in Cynomolgus Macaques.
    Wickham LA; Sitko G; Stranieri-Michener M; Handt L; Basso A; Fried S; Chu L; Maderia M; Owens K; Castriota G; Chen Z; Metzger JM; Imbriglio J; Wang X; Cai TQ
    Thromb Res; 2016 Sep; 145():133-9. PubMed ID: 27318768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of indole derived protease-activated receptor 4 antagonists and characterization in human platelets.
    Young SE; Duvernay MT; Schulte ML; Lindsley CW; Hamm HE
    PLoS One; 2013; 8(6):e65528. PubMed ID: 23776495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel and orally active thrombin receptor antagonist E5555 (Atopaxar) inhibits arterial thrombosis without affecting bleeding time in guinea pigs.
    Kogushi M; Matsuoka T; Kawata T; Kuramochi H; Kawaguchi S; Murakami K; Hiyoshi H; Suzuki S; Kawahara T; Kajiwara A; Hishinuma I
    Eur J Pharmacol; 2011 Apr; 657(1-3):131-7. PubMed ID: 21300059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
    Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets.
    Etulain J; Mena HA; Negrotto S; Schattner M
    Platelets; 2015; 26(8):799-804. PubMed ID: 26082997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A trypsin-like platelet protease propagates protease-activated receptor-1 cleavage and platelet activation.
    Ofosu FA; Freedman J; Dewar L; Song Y; Fenton JW
    Biochem J; 1998 Dec; 336 ( Pt 2)(Pt 2):283-5. PubMed ID: 9820801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protease-activated receptors and platelet function.
    Coughlin SR
    Thromb Haemost; 1999 Aug; 82(2):353-6. PubMed ID: 10605724
    [No Abstract]   [Full Text] [Related]  

  • 40. RWJ-58259: a selective antagonist of protease activated receptor-1.
    Damiano BP; Derian CK; Maryanoff BE; Zhang HC; Gordon PA
    Cardiovasc Drug Rev; 2003; 21(4):313-26. PubMed ID: 14647534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.